GentleCure Blog

Skin Cancer Research: New Treatments and Advances

Eyeglasses resting on a blue background with blurred medical text about skin cancer

Skin cancer research continues to improve how doctors diagnose, treat, and manage different types of skin cancer. From advances in immunotherapy and targeted medications to improvements in radiation treatment and surgery, researchers are exploring ways to make treatment more effective and better suited to individual patients.

Recent developments have been especially important for people with advanced melanoma, basal cell skin cancer, and squamous cell skin cancer. However, treatment options differ significantly depending on the type of skin cancer, its location, and whether it has spread.

Learn about current skin cancer treatments, areas of ongoing research, and how newer approaches may influence treatment decisions.

What Are the Latest Advances in Skin Cancer Treatment?

Skin cancer treatment has advanced through research into how cancer develops, responds to treatment, and interacts with the immune system.

Important areas of progress include:

  • Immunotherapy: Treatments that help the body’s immune system recognize and attack cancer cells.
  • Targeted therapy: Medications that act on specific molecular pathways involved in cancer growth.
  • Personalized medicine: Using tumor characteristics and other patient information to guide treatment decisions.
  • Radiation treatment technology: Improving how radiation is planned, delivered, and monitored.
  • Combination treatments: Studying whether multiple treatment approaches may work more effectively together.

Not every approach is appropriate for every skin cancer. Some are established treatment options for specific diagnoses, while others remain under investigation in clinical trials.

Research and Treatment Advances for Basal Cell and Squamous Cell Skin Cancers

Basal cell skin cancer and squamous cell skin cancer are the two most common forms of nonmelanoma skin cancer.

When detected early, these skin cancers can often be treated successfully with established methods, including surgical excision, Mohs surgery, and selected surgery-free treatments.

However, some cases are more complex. Skin cancers that grow deeper into surrounding tissue, recur after treatment, or cannot be managed with conventional local therapies may require additional approaches.

Research into targeted medications and immunotherapy has expanded treatment possibilities for certain advanced cases.

Targeted Therapy for Advanced Basal Cell Skin Cancer

Targeted therapies work by interfering with specific signals that cancer cells use to grow.

For certain advanced basal cell skin cancers, doctors may use medications called Hedgehog pathway inhibitors.

These include vismodegib and sonidegib.

Such medications may be appropriate for selected patients when surgery or radiation is not suitable.

Researchers continue investigating ways to improve treatment responses, reduce side effects, and address resistance that may develop over time.

Immunotherapy for Advanced Skin Cancer

Immunotherapy helps the immune system recognize and respond to cancer.

Some skin cancer cells use mechanisms that prevent immune cells from attacking them effectively. Certain immunotherapy medications block these mechanisms, allowing the immune system to respond more actively.

For selected patients with advanced squamous cell skin cancer, treatment options may include medications such as cemiplimab, pembrolizumab, or cosibelimab.

Immunotherapy may also be considered in certain advanced basal cell skin cancer cases.

These treatments are not appropriate for every patient. Eligibility depends on the diagnosis, previous treatments, cancer characteristics, and overall health.

Can Targeted Therapy and Immunotherapy Be Combined?

Researchers are investigating whether combining treatments, or using them at different stages of care, can improve outcomes for patients with advanced skin cancer.

Clinical studies explore questions such as whether treatment can shrink tumors before surgery, reduce the risk of recurrence, or help patients whose cancers have stopped responding to previous medications.

These approaches require careful clinical evaluation because combinations may introduce additional risks and side effects.

Image-Guided SRT: Advances in Surgery-Free Skin Cancer Treatment

Image-Guided Superficial Radiation Therapy, also known as Image-Guided SRT or IGSRT, is a surgery-free treatment option for certain nonmelanoma skin cancers, including selected basal cell and squamous cell skin cancers.

The technology combines high-frequency ultrasound imaging with targeted radiation therapy.

Ultrasound imaging helps the treating provider examine and monitor the affected area during treatment, while radiation is delivered according to the prescribed treatment plan.

For eligible patients, this approach may offer an alternative to surgery without cutting or stitches.

Treatment suitability depends on the type of skin cancer, tumor size, depth, location, medical history, and provider recommendation.

IGSRT is distinct from systemic therapies such as immunotherapy and targeted medications. Those approaches are generally used for different clinical situations.

Can GentleCure IGSRT Treat Melanoma?

No. GentleCure IGSRT is not a treatment for melanoma.

Melanoma is a different type of skin cancer that requires its own diagnostic evaluation and treatment approach.

Depending on its stage and other characteristics, melanoma treatment may involve surgery, immunotherapy, targeted therapy, or a combination of treatments.

GentleCure focuses on helping eligible patients learn about Image-Guided SRT for certain nonmelanoma skin cancers, particularly basal cell and squamous cell skin cancers.

Anyone diagnosed with melanoma should discuss appropriate treatment options with a qualified healthcare provider.

Current Melanoma Research and Treatment Advances

Melanoma research has produced important advances in recent years, especially for patients with cancers that have spread or are at higher risk of returning.

Surgery remains an important treatment for many cases of early-stage melanoma.

For certain more advanced cases, doctors may also recommend systemic treatments that work throughout the body.

Immunotherapy for Melanoma

Immune checkpoint inhibitors are an established treatment option for selected patients with melanoma.

These medications help immune cells recognize and attack cancer cells more effectively.

Researchers continue studying which patients are most likely to benefit, how different medications can be combined, and whether immunotherapy should be given before or after surgery.

Targeted Therapy for Melanoma

Some melanomas contain specific genetic mutations that influence how cancer cells grow.

For eligible patients, targeted medications can interfere with these molecular pathways.

Genetic testing of a tumor may help healthcare providers determine whether a targeted treatment is appropriate.

Research continues into resistance, treatment combinations, and strategies for improving long-term outcomes.

Personalized Cell Therapy and New Research Directions

Another area of melanoma research involves using a patient’s immune cells to help fight cancer.

One approach, called tumor-infiltrating lymphocyte (TIL) therapy, uses immune cells collected from a patient’s tumor. These cells are expanded in a laboratory and later returned to the patient.

TIL therapy is an option for certain patients with previously treated advanced melanoma.

Researchers are also studying personalized vaccines and other immune-based treatments that may help reduce recurrence or improve responses to existing therapies.

Many of these approaches are still being evaluated, and their availability depends on the patient’s diagnosis and clinical circumstances.

How Do Clinical Trials Help Advance Skin Cancer Treatment?

Clinical trials help researchers evaluate the safety and effectiveness of new treatments, treatment combinations, and care strategies.

Depending on the study, researchers may investigate:

  • New immunotherapy medications
  • Targeted treatments for specific mutations
  • Ways to reduce treatment side effects
  • Treatment combinations for advanced skin cancer
  • Approaches to reduce recurrence
  • Improvements in radiation and other local therapies

Some trials compare new approaches with established treatments. Others evaluate whether a treatment may benefit people whose cancer has not responded to previous care.

Participating in a clinical trial is a personal medical decision. A healthcare provider can explain potential benefits, risks, eligibility requirements, and available alternatives.

How Can Patients Learn About New Skin Cancer Treatments?

Patients interested in treatment advances should start by discussing their diagnosis and available options with their dermatologist or treating specialist.

Helpful questions include:

  • What type of skin cancer do I have?
  • Is my skin cancer considered low risk or high risk?
  • Which treatments are appropriate for my diagnosis?
  • Are there surgery-free options I should consider?
  • Would additional testing affect my treatment plan?
  • Are there relevant clinical trials or newer treatments available?
  • What follow-up care will I need?

Reliable medical resources and ongoing discussions with healthcare providers can help patients understand how research findings may apply to their situation.

FAQ: Skin Cancer Research and New Treatments

What are the newest treatments for skin cancer?

Treatment advances include newer immunotherapy medications, targeted therapies, personalized cellular treatments, and improvements in radiation technology. The appropriate treatment depends on the specific type and stage of skin cancer.

Is there a surgery-free treatment for basal cell skin cancer?

Yes. Depending on the diagnosis, certain basal cell skin cancers may be treated with surgery-free approaches such as selected topical medications or radiation therapy, including IGSRT for eligible patients.

Can squamous cell skin cancer be treated with immunotherapy?

Yes. Immunotherapy may be appropriate for certain patients with advanced squamous cell skin cancer, particularly when other treatments are unsuitable or insufficient.

What is the difference between immunotherapy and targeted therapy?

Immunotherapy helps the immune system recognize and respond to cancer cells. Targeted therapy interferes with specific biological pathways involved in cancer growth.

Is melanoma treated the same way as basal cell skin cancer?

No. Melanoma and basal cell skin cancer are different diseases, and their treatment approaches can vary significantly. Treatment decisions depend on diagnosis, stage, and individual clinical factors.

Does GentleCure IGSRT treat melanoma?

No. GentleCure IGSRT is used for selected nonmelanoma skin cancers and is not a treatment for melanoma.

Are new skin cancer treatments available through clinical trials?

Yes. Clinical trials continue to investigate new therapies and treatment combinations. Availability and eligibility vary by study and diagnosis.

Learn More About Surgery-Free Skin Cancer Treatment Options

Advances in skin cancer research are helping patients and healthcare providers make more informed treatment decisions.

For people diagnosed with certain basal cell or squamous cell skin cancers, Image-Guided SRT may be an option worth discussing with a dermatologist.

GentleCure IGSRT is a surgery-free treatment option for eligible patients with certain nonmelanoma skin cancers.

To learn more, call 855-936-4411 to speak with a Skin Cancer Information Specialist or find a participating dermatology practice near you.

How would you rate this page?



For more information on skin cancer treatment options, speak with a Skin Cancer Information Specialist today.

Help protect and expand insurance coverage for Image-Guided SRT by participating in change.